195 related articles for article (PubMed ID: 10528941)
1. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drugs in development: prospects for the near future.
Leppik IE
Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
[TBL] [Abstract][Full Text] [Related]
3. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
4. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Hutton JL; Chadwick DW
Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
Johannessen SI
Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
[TBL] [Abstract][Full Text] [Related]
6. An audit of the new antiepileptic drugs in clinical neurological practice.
McDonnell GV; Morrow JI
Seizure; 1996 Jun; 5(2):127-30. PubMed ID: 8795128
[TBL] [Abstract][Full Text] [Related]
7. Overview of the safety of newer antiepileptic drugs.
Shorvon S; Stefan H
Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
[TBL] [Abstract][Full Text] [Related]
8. The outcome of prescribing novel anticonvulsants in an outpatient setting: factors affecting response to medication.
Thijs RD; Kerr MP
Seizure; 1998 Oct; 7(5):379-83. PubMed ID: 9808113
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
Perucca E
Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245
[TBL] [Abstract][Full Text] [Related]
10. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
Devinsky O; Vazquez B; Luciano D
J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
[TBL] [Abstract][Full Text] [Related]
11. New antiepileptic drugs--an explosion of activity.
Leach JP; Brodie MJ
Seizure; 1995 Mar; 4(1):5-17. PubMed ID: 7788108
[TBL] [Abstract][Full Text] [Related]
12. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Schapel G; Chadwick D
Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
[TBL] [Abstract][Full Text] [Related]
13. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
14. The role of newer anticonvulsants in the management of epilepsy.
Kilpatrick C
Aust N Z J Med; 1995 Apr; 25(2):114-6. PubMed ID: 7605291
[No Abstract] [Full Text] [Related]
15. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Chadwick DW
BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
[TBL] [Abstract][Full Text] [Related]
16. A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities.
Bhaumik S; Branford D; Duggirala C; Ismail IA
Seizure; 1997 Apr; 6(2):127-33. PubMed ID: 9153725
[TBL] [Abstract][Full Text] [Related]
17. Advances in the pharmacotherapy of epilepsy.
Ramsay RE
Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715
[TBL] [Abstract][Full Text] [Related]
18. The use of new antiepileptic medications in pediatric patients with epilepsy.
Carter JR
J Pediatr Health Care; 1994; 8(6):277-82. PubMed ID: 7799203
[No Abstract] [Full Text] [Related]
19. Recent advancements in epilepsy.
Wyler AR; Vossler DG
Surg Neurol; 1997 Aug; 48(2):106-9. PubMed ID: 9242233
[TBL] [Abstract][Full Text] [Related]
20. Novel antiepileptic drugs: nursing implications.
Byers VL
J Neurosci Nurs; 1993 Dec; 25(6):375-9. PubMed ID: 8106833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
